世界のイピリムマブ市場:販売動向2018

Table of Contents

Global Ipilimumab Sales Market Report 2017
1 Ipilimumab Market Overview
1.1 Product Overview and Scope of Ipilimumab
1.2 Classification of Ipilimumab by Product Category
1.2.1 Global Ipilimumab Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Ipilimumab Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3
1.2.4
1.3 Global Ipilimumab Market by Application/End Users
1.3.1 Global Ipilimumab Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Global Ipilimumab Market by Region
1.4.1 Global Ipilimumab Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Ipilimumab Status and Prospect (2012-2022)
1.4.3 China Ipilimumab Status and Prospect (2012-2022)
1.4.4 Europe Ipilimumab Status and Prospect (2012-2022)
1.4.5 Japan Ipilimumab Status and Prospect (2012-2022)
1.4.6 Southeast Asia Ipilimumab Status and Prospect (2012-2022)
1.4.7 India Ipilimumab Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Ipilimumab (2012-2022)
1.5.1 Global Ipilimumab Sales and Growth Rate (2012-2022)
1.5.2 Global Ipilimumab Revenue and Growth Rate (2012-2022)

2 Global Ipilimumab Competition by Players/Suppliers, Type and Application
2.1 Global Ipilimumab Market Competition by Players/Suppliers
2.1.1 Global Ipilimumab Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Ipilimumab Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Ipilimumab (Volume and Value) by Type
2.2.1 Global Ipilimumab Sales and Market Share by Type (2012-2017)
2.2.2 Global Ipilimumab Revenue and Market Share by Type (2012-2017)
2.3 Global Ipilimumab (Volume and Value) by Region
2.3.1 Global Ipilimumab Sales and Market Share by Region (2012-2017)
2.3.2 Global Ipilimumab Revenue and Market Share by Region (2012-2017)
2.4 Global Ipilimumab (Volume) by Application

3 United States Ipilimumab (Volume, Value and Sales Price)
3.1 United States Ipilimumab Sales and Value (2012-2017)
3.1.1 United States Ipilimumab Sales and Growth Rate (2012-2017)
3.1.2 United States Ipilimumab Revenue and Growth Rate (2012-2017)
3.1.3 United States Ipilimumab Sales Price Trend (2012-2017)
3.2 United States Ipilimumab Sales Volume and Market Share by Players
3.3 United States Ipilimumab Sales Volume and Market Share by Type
3.4 United States Ipilimumab Sales Volume and Market Share by Application

4 China Ipilimumab (Volume, Value and Sales Price)
4.1 China Ipilimumab Sales and Value (2012-2017)
4.1.1 China Ipilimumab Sales and Growth Rate (2012-2017)
4.1.2 China Ipilimumab Revenue and Growth Rate (2012-2017)
4.1.3 China Ipilimumab Sales Price Trend (2012-2017)
4.2 China Ipilimumab Sales Volume and Market Share by Players
4.3 China Ipilimumab Sales Volume and Market Share by Type
4.4 China Ipilimumab Sales Volume and Market Share by Application

5 Europe Ipilimumab (Volume, Value and Sales Price)
5.1 Europe Ipilimumab Sales and Value (2012-2017)
5.1.1 Europe Ipilimumab Sales and Growth Rate (2012-2017)
5.1.2 Europe Ipilimumab Revenue and Growth Rate (2012-2017)
5.1.3 Europe Ipilimumab Sales Price Trend (2012-2017)
5.2 Europe Ipilimumab Sales Volume and Market Share by Players
5.3 Europe Ipilimumab Sales Volume and Market Share by Type
5.4 Europe Ipilimumab Sales Volume and Market Share by Application

6 Japan Ipilimumab (Volume, Value and Sales Price)
6.1 Japan Ipilimumab Sales and Value (2012-2017)
6.1.1 Japan Ipilimumab Sales and Growth Rate (2012-2017)
6.1.2 Japan Ipilimumab Revenue and Growth Rate (2012-2017)
6.1.3 Japan Ipilimumab Sales Price Trend (2012-2017)
6.2 Japan Ipilimumab Sales Volume and Market Share by Players
6.3 Japan Ipilimumab Sales Volume and Market Share by Type
6.4 Japan Ipilimumab Sales Volume and Market Share by Application

7 Southeast Asia Ipilimumab (Volume, Value and Sales Price)
7.1 Southeast Asia Ipilimumab Sales and Value (2012-2017)
7.1.1 Southeast Asia Ipilimumab Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Ipilimumab Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Ipilimumab Sales Price Trend (2012-2017)
7.2 Southeast Asia Ipilimumab Sales Volume and Market Share by Players
7.3 Southeast Asia Ipilimumab Sales Volume and Market Share by Type
7.4 Southeast Asia Ipilimumab Sales Volume and Market Share by Application

8 India Ipilimumab (Volume, Value and Sales Price)
8.1 India Ipilimumab Sales and Value (2012-2017)
8.1.1 India Ipilimumab Sales and Growth Rate (2012-2017)
8.1.2 India Ipilimumab Revenue and Growth Rate (2012-2017)
8.1.3 India Ipilimumab Sales Price Trend (2012-2017)
8.2 India Ipilimumab Sales Volume and Market Share by Players
8.3 India Ipilimumab Sales Volume and Market Share by Type
8.4 India Ipilimumab Sales Volume and Market Share by Application

9 Global Ipilimumab Players/Suppliers Profiles and Sales Data
9.1 Bristol-Myers Squibb
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Ipilimumab Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Bristol-Myers Squibb Ipilimumab Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview

10 Ipilimumab Maufacturing Cost Analysis
10.1 Ipilimumab Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Ipilimumab
10.3 Manufacturing Process Analysis of Ipilimumab

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Ipilimumab Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Ipilimumab Major Manufacturers in 2016
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Ipilimumab Market Forecast (2017-2022)
14.1 Global Ipilimumab Sales Volume, Revenue and Price Forecast (2017-2022)
14.1.1 Global Ipilimumab Sales Volume and Growth Rate Forecast (2017-2022)
14.1.2 Global Ipilimumab Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Ipilimumab Price and Trend Forecast (2017-2022)
14.2 Global Ipilimumab Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
14.2.1 Global Ipilimumab Sales Volume and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global Ipilimumab Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.3 United States Ipilimumab Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 China Ipilimumab Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Europe Ipilimumab Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 Japan Ipilimumab Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia Ipilimumab Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.8 India Ipilimumab Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Ipilimumab Sales Volume, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global Ipilimumab Sales Forecast by Type (2017-2022)
14.3.2 Global Ipilimumab Revenue Forecast by Type (2017-2022)
14.3.3 Global Ipilimumab Price Forecast by Type (2017-2022)
14.4 Global Ipilimumab Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

facebooktwittergoogle_plusredditpinterestlinkedinmail